Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
Donna Holder
Donna Holder is the Senior Director, Global MSL Excellence at Daiichi Sankyo Inc (DSI) where she is accountable for ensuring the strategic alignment of MSL activities across DSI regions, and for strengthening the MSL capability worldwide. Donna has over 25 years of experience in the pharmaceutical industry with a wealth of experience in Medical Affairs. Most recently she was the Executive Director, Global Field Medical Center of Excellence (CoE) at Merck from January 2018 to May 2020 where she was responsible for the Field Medical capability worldwide along with the leadership of scientific and capability training function for Field Medical.
She started her career at Marion Merrell Dow (now Sanofi) in Clinical Development and then joined AstraMerck (now AstraZeneca Pharmaceuticals) where she spent over ten years in senior leadership roles including leadership of MSL, Medical Information, and Contact Center teams. In her last role at AZ as Senior Director, MSL Excellence in Global Medical Affairs, Donna was accountable for the strategic direction of the MSL function. She led development, delivery, and measurement of initiatives to strengthen MSL capabilities worldwide. Donna left AZ at the end of 2014 and became a Medical Affairs consultant, partnering with pharmaceutical and biotech clients to deliver solutions including capability development, business process development, business strategy, operations management, and coaching. Donna earned her Doctor of Pharmacy from the University of Michigan.
Anna Walz
Anna Walz is a 25+ year veteran in the pharmaceutical industry. She is the Founder and CEO Emeritus of MedEvoke, a MEDISTRAVA Company (Medical Division of Huntsworth). MedEvoke is a global medical consulting firm dedicated to working with Medical Affairs leaders to drive alignment through development of clear medical strategies that can be globally communicated, measured, and analyzed. This has, for the first time, enabled Medial Affairs to track the impact of internal efforts on the external scientific and digital exchanges.
Anna currently serves as Senior Strategic Advisor to MEDISTRAVA and provides professional guidance on the formation of a cross-company Medical Analytics Function that will overlay the community of medical affairs agencies within the healthcare division of Huntsworth. Her external responsibilities include working with key clients and professional organizations on market implementation and validation of the medical analytics function. Internal responsibilities include providing input on annual strategy planning process and relevant roll-out workstreams. Anna also serves of the Board of Directors for Healios AG, a Swiss-based medical device software manufacturer that is dedicated to finding solutions in clinical research and patient monitoring through innovative digital technologies.
Anna, who often speaks on the topics of medical strategy, launch excellence, impact metrics for medical affairs, female entrepreneurship, and diversity in the biosciences, is also a regular guest-lecturer on the topic of Pharmacology & Drug Marketing at the Rutgers Medical School. In addition to speaking, Anna has a keen interest in her own continuing education and is a graduate of both the Tuck-WBENC Executive Education program and the Entrepreneurial Master’s Program (EMP), a joint collaboration of the Entrepreneurs’ Organization (EO) and the Massachusetts Institute of Technology (MIT).
Anna has been one of the most vocal champions for MAPS since its inception, has served as Co-Chair of the Standards & Guidance Committee, and is currently serving on the organization’s Board of Directors and on the Fund Development Committee.
